We can't find the internet
Attempting to reconnect
Something went wrong!
Hang in there while we get back on track
Exploring the efficacy of Benincasa hispida extract on obesity linked inflammatory bowel disease by integrating computational analysis and experimental validations
AI summary Read the abstract
Researchers used computational analysis and animal experiments to evaluate whether compounds from the wax gourd plant could help treat obesity-related inflammatory bowel conditions. They identified several promising bioactive compounds that showed favorable drug-like properties and interaction with key inflammatory pathways. While this study focuses on a plant-based therapeutic approach rather than microplastic pollution directly, it contributes to understanding inflammation in the gut.
The association of obesity with inflammatory bowel disease (IBD) can be understood by the intricate role of pro- and anti-inflammatory cytokines, especially adipokines, which are secreted by adipose tissue and are responsible for IBD because of their structural similarity with tumor necrosis factor-alpha (TNF-α), an important cytokine involved in IBD pathogenesis. The current study was carried out to evaluate the therapeutic potential of Benincasa hispida in obesity-associated IBD. Approximately 18 compounds sourced from Benincasa hispida (Thunb.) were comprehensively analyzed, among which 11 presented favorable drug-likeness scores and adherence to Lipinski's Rule of Five. Various methodologies, including compound-gene set pathway enrichment analysis, network pharmacology, docking studies, and molecular dynamics simulations, have been employed. Safety assessments via Protox confirmed the nontoxic nature of these compounds, which is crucial for their therapeutic potential. Through Venn diagram analysis of the Gene Card and OMIM databases, proteins associated with obesity and IBD management were pinpointed. Pathway enrichment analysis revealed 810 targets across 192 distinct pathways, with 8 directly related to the pathogenesis of obesity and IBD. Notable therapeutic targets, such as MTOR, were identified through STRING and KEGG pathway database analyses, shedding light on the molecular pathways modulated by these protein targets. Interactions among compounds, proteins, and pathways were visualized via Cytoscape 3.6.1. Furthermore, the compounds were docked with the protein target via AutoDock 4.2, and the compound ajmalin exhibited the highest binding affinity with the MTOR protein, with a binding energy of -7.8 kcal/mol; later, a dynamic study was performed for the ajmaline and protein complex. These findings shed light on the potential efficacy of Benincasa hispida in targeting crucial pathways for managing obesity and IBD. Hence, in vivo studies involving Wistar rats exposed to microplastics and monosodium glutamate (MSG) were carried out to evaluate the potential of Benincasa hispida extracts in mitigating obesity-related IBD. Fecal lipid analysis revealed alterations associated with these conditions, whereas histopathological examinations of the liver and intestine revealed the inflammatory changes induced by MSG and microplastics. The protective effects of this extract on liver and intestinal histology suggest promising avenues for further investigations, emphasizing its potential as a therapeutic intervention for IBD and obesity.
More Papers Like This
Microplastic exposure and obesity-related metabolic dysfunction: A proposed gut microbiota-metabolite framework.
AI summary Read the abstract
This review paper summarizes existing research on how microplastics eaten with food might affect gut bacteria, gut lining health, and body fat in animal studies and lab cell experiments. It suggests microplastics could disrupt gut microbes and cause inflammation linked to obesity-related problems, but notes gaps in long-term testing and uncertainty about applying findings across species.
Analysis of Microplastics in Human Feces Reveals a Correlation between Fecal Microplastics and Inflammatory Bowel Disease Status
AI summary Read the abstract
Researchers found higher concentrations and greater diversity of microplastics in fecal samples from inflammatory bowel disease patients compared to healthy controls, suggesting a potential association between microplastic ingestion and gut inflammation, though causality remains to be established.
Quantifying the influence of micro and nanoplastics characteristics on cytotoxicity in caco-2 cells through machine learning modelling.
AI summary Read the abstract
This systematic review uses machine learning to identify which characteristics of micro and nanoplastics are most toxic to intestinal cells. The researchers found that particle size, shape, and concentration all play important roles in how much damage these plastics cause to gut lining cells, helping us understand how ingested microplastics might affect digestive health.
The role of microplastics in the pathogenesis of inflammatory bowel diseases
AI summary Read the abstract
This review of existing research found that tiny plastic particles we eat and drink may contribute to inflammatory bowel diseases like Crohn's disease and ulcerative colitis. The plastic bits can damage the gut lining, cause inflammation, and disrupt the healthy bacteria in our intestines. While more research is needed to confirm the connection, this suggests that reducing plastic pollution could be important for protecting our digestive health.
Research digests by email
When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.